In 2024, SIA Pharma Nord had revenue of 354.9 thousand EUR and profit of 6.4 thousand EUR. The company has 4 employees. Beneficial owners: Eli Wallin.
year | Revenue | Profit | Assets | Liabilities | Equity | Employees |
|---|---|---|---|---|---|---|
| 2024 | 354 932 € -19.8% | 6389 € -77.8% | 419 911 € +7.6% | 389 562 € | 30 349 € | 4 -20.0% |
| 2023 | 442 819 € +32.1% | 28 770 € +111.0% | 390 135 € +47.0% | 337 175 € | 52 960 € | 5 +0.0% |
| 2022 | 335 306 € +5.8% | 13 637 € +42.1% | 265 368 € +4.9% | 228 178 € | 37 190 € | 5 +0.0% |
| 2021 | 316 966 € -20.3% | 9598 € -24.5% | 253 002 € +1.2% | 216 449 € | 35 553 € | 5 +0.0% |
Overall Rating | A+92/100 |
Financial Health | 100/100 |
Credit History | 100/100 |
Legal History | 100/100 |
Business Activity | 50/100 |
| Overall Risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, Surname | Position | Representation Rights | Registered | |
|---|---|---|---|---|
| Board Chairman | Together with at least | |||
| Board Member | Together with at least |
| Name | Changed |
|---|---|
| SIA "Pharma Nord" | 7 February 2005 |
SIA Pharma Nord is located at Rīga, Kleistu iela 24.
In 2024, SIA Pharma Nord had revenue of 354 932 EUR and profit of 6389 EUR. Compared to previous year, revenue decreased by 19.8%. View full financial report →
In 2024, SIA Pharma Nord had an average of 4 employees. View tax history →
The beneficial owners of SIA Pharma Nord are Eli Wallin. View ownership details →
Yes, SIA Pharma Nord is registered as an active VAT payer with VAT number LV40003501290.
In 2024, the average gross salary at SIA Pharma Nord was approximately 1764,32 € per month (net ~ 1306,46 €). This is an approximate calculation. View salary details →
SIA Pharma Nord was founded on July 7, 2000. The company has been operating for 26 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company Age | 26 years | - | 0% | |
Net Revenue | 354 932,00 € | - | 0% | |
Profit | 6389,00 € | - | 0% | |
Equity | 30 349,00 € | - | 0% | |
Assets | 419 911,00 € | - | 0% | |
Fixed Assets | 2049,00 € | - | 0% | |
Liquidity | 1.07 | - | 40% | |
Profitability | 1.8% | - | 10% | |
Registered Capital | 2828,00 € | - | 0% |
| Name, Surname | Shares | Ownership Rights | |
|---|---|---|---|
| PHARMA NORD ApS | 101 | 100.00% |
| Name, Surname | Nationality | Birth Date | |
|---|---|---|---|
| Eli Wallin | - |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Annual financial report for 2018.
Annual financial report for 2017.
Registered in the Latvian Company Register.